Nomura Holdings
RCUS icon

Nomura Holdings’s Arcus Biosciences RCUS Stock Holding History

Nomura Holdings’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.75M Buy
80,900
+29,800
+58% +$644K ﹤0.01% 968
2025
Q4 		$1.22M Buy
51,100
+30,000
+142% +$612K ﹤0.01% 1270
2025
Q3 		$287K Hold
21,100
– – ﹤0.01% 1707
2025
Q2 		$172K Buy
+21,100
New +$180K ﹤0.01% 1316

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Nomura Holdings's RCUS Position: Q3 2025 in Review

Nomura Holdings sold out of Arcus Biosciences (RCUS) in Q3 2025, closing a stake of 15,603 shares — an estimated $162K sold.

Nomura Holdings first reported a position in RCUS in Q2 2025 and held it in 1 quarter. The position peaked at $127K in Q2 2025. 190 funds tracked by Wall St. Rank hold RCUS as of Q3 2025.

  • Nomura Holdings reported no remaining Arcus Biosciences position as of Q3 2025 after selling out during the quarter.
  • Nomura Holdings sold 15,603 Arcus Biosciences shares in Q3 2025, an estimated $162K.
  • Nomura Holdings first reported a position in Arcus Biosciences in Q2 2025 and held it in 1 quarter.
  • Nomura Holdings's Arcus Biosciences position peaked at $127K in Q2 2025.
  • 190 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2025.

Based on Nomura Holdings's 13F filing for Q3 2025, filed 14 Nov 2025.